Pyrovalerone Analogues and Therapeutic Uses Thereof
申请人:Butler David
公开号:US20080234498A1
公开(公告)日:2008-09-25
New compounds that bind to monoamine transporters are described. The compounds of the present invention can be racemic or pure R— or S-enantiomers. Certain preferred compounds of the present invention have a high selectively dopamine transporter versus the serotonin transporter. Preferred monoamine transporters for the practice of the present invention include the dopamine transporter, the serotonin transporter and the norepinephrine transporter.
[EN] PYROVALERONE ANALOGS AND THERAPEUTIC USES THEREOF<br/>[FR] ANALOGUES DE PYROVALERONE ET UTILISATIONS THERAPEUTIQUES
申请人:HARVARD COLLEGE
公开号:WO2005034878A2
公开(公告)日:2005-04-21
New compounds that bind to monoamine transporters are described. The compounds of the present invention can be racemic or pure R-or S-enantiomers. Certain preferred compounds of the present invention have a high selectively dopamine transporter versus the serotonin transporter. Preferred monoamine transporters for the practice of the present invention include the dopamine transporter, the serotonin transporter and the norepinephrine transporter.
10.1002/chir.23679
作者:Seibert, Elisabeth、Götz, Katharina、Schmid, Martin G.
DOI:10.1002/chir.23679
日期:——
commercially available Lux® i‐Amylose‐3 column by HPLC‐UV for enantiorecognition of cathinone derivatives. Overall, 80 compounds were tested in normal phase mode, where 75 substances were separated under initial conditions. After method optimization, at least partial separation was achieved for the remaining compounds. The same set of substances was measured in polar‐organic mode, where 63 analytes were resolved